FDA warning flags up delta-8 THC as the likely next target for US enforcement

Enforcement action against companies pushing the limits on marketing delta-8 THC products in the US is likely following a consumer update and a health advisory from the US Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC).

The FDA said it had noted delta-8 being marketed for therapeutic or medical uses and products whose presentation and marketing could be construed as being appealing to children as part of a consumer update stemming from a rise in related notifications.


Benefits of subscription plans:

  • Stay informed of any legal and market change in the sector that impacts your organization
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Need help?

Contact a sales representative right now and don’t wait

Erik Galavis
+34 654 320 547
Email Erik

Pablo Sharrock
+34 722 642 678
Email Pablo